Navigation Links
Diabetes, Metabolic Syndrome and Cardiovascular Disease
Date:11/21/2013

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/98bhmb/diabetes) has announced the addition of the "Diabetes, Metabolic Syndrome and Cardiovascular Disease" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among adults across the world. To compound the global diabetes epidemic, health professionals are witnessing an alarming increase in inflammatory diseases resulting from adult onset (i.e., Type 2) diabetes. This phenomenon is referred to as "metabolic syndrome" where a confluence of inflammatory conditions occur along with the diabetes. As a result, growing evidence appears to show that metabolic syndrome makes the diabetic patient susceptible to degenerative health conditions such as cardiovascular disease, stroke and, now believed, Alzheimer's disease. As the diabetes epidemic escalates, a new sense of urgency has taken hold. Proactive strategies for prevention of the disease are being put in place by international health organizations such as the World Health Organization (WHO), as well as by the health departments of industrialized and developing countries, and even at the local level where food ingredients regulations are being passed.

This report charts the changing landscape of the global diabetic population and explores the added health concerns resulting from the metabolic syndrome phenomenon and one of its major risk factors: cardiovascular disease (CVD). Furthermore, this study evaluates widely-accepted therapeutic approaches to diabetes that are currently in use, while providing an in-depth analysis of emerging technologies that will be used to treat diabetes and other inflammatory diseases in the future.

Key Topics Covered:

1. Overview

2. Introduction

3. Understanding the Metabolic Conditions Underlying and Associated with Diabetes

4. Pharmaceutical Industry and the Anti-Diabetes Market

5. Non-Insulin Anti-Diabetes Products

6. Insulin

7. Emerging Anti-Diabetes Products

8. Diagnosing Diabetes Using In Vitro Laboratory Tests

9. Market Trends, Challenges and Strategic Options

10. Company Profiles

Companies Mentioned

- Menarini
- Abbott Laboratories
- Amgen
- AstraZeneca
- Bayer
- BodyMedia
- Cybermedical
- Debiotech
- DexCom
- Echo Therapeutics
- Elixir Pharmaceuticals
- Eksigent
- Flamel Technologies
- GlaxoSmithKline
- GlucoLight
- Insulet
- iSense Corporation
- Isis Pharmaceuticals, Inc.
- Johnson & Johnson
- KYORIN
- M-Biotech
- Medtronic
- Merck & Co.
- Merck KGaA
- MicroIslet
- Mitsubishi Tanabe Pharma Corporation
- Nipro Diabetes Systems
- Novartis
- Novo Nordisk
- Novocell
- ONO Pharmaceutical
- Orexigen Therapeutics
- Pfizer
- ReNeuron
- Roche Diagnostics
- Sanofi-Aventis
- Siemens
- Smiths Medical
- Servier
- SOOIL Development
- Takeda
- TheraFuse
- Teco Diagnostics
- Transition Therapeutics
- U.S. Diagnostics
- VeraLight
- Vivus
- Ypsomed Holding

For more information visit http://www.researchandmarkets.com/research/98bhmb/diabetes

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. La célebre chef Leticia Moreinos Schwartz se asocia con Merck en el marco del programa Cuida tu Diabetes, Cuida tu Corazón para preparar deliciosos platos para diabéticos destinados a los hispanos que padecen diabetes tipo 2
2. Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Cuida tu Diabetes, Cuida tu Corazon to Cook up Delicious, Diabetes-Friendly Dishes for Hispanics with Type 2 Diabetes
3. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
4. Whats Next In Vaccines (Malaria, Diabetes, Alzheimers, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
5. Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimers Drug Discovery
6. KemPharms KP201 Demonstrates Complete Metabolic Cleavage of Prodrug and Steady-State Pharmacokinetic Profiles for Hydrocodone, Hydromorphone and Acetaminophen
7. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
8. Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs
9. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
10. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
11. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):